300896 爱美客
交易中 12-23 11:22:03
资讯
新帖
简况
爱美客:公司研发项目情况会按照相关法规要求在定期报告中进行披露
证券之星 · 12-16
爱美客:公司研发项目情况会按照相关法规要求在定期报告中进行披露
12月13日爱美客跌5.67%,华宝中证医疗ETF基金重仓该股
证券之星 · 12-13
12月13日爱美客跌5.67%,华宝中证医疗ETF基金重仓该股
爱美客(300896)12月10日股东户数6.01万户,较上期减少1.29%
证券之星 · 12-11
爱美客(300896)12月10日股东户数6.01万户,较上期减少1.29%
爱美客:截至2024年12月10日,公司股东人数为60,082户
证券之星 · 12-11
爱美客:截至2024年12月10日,公司股东人数为60,082户
4.63亿元市值限售股今日解禁,美邦科技、外服控股、爱美客解禁市值居前
界面 · 12-11
4.63亿元市值限售股今日解禁,美邦科技、外服控股、爱美客解禁市值居前
爱美客今日在互动平台表示,截至目前公司产品及服务未应用到AI技术。
美港电讯 · 12-10
爱美客今日在互动平台表示,截至目前公司产品及服务未应用到AI技术。
爱美客(300896.SZ):重组人透明质酸酶注射液获药物临床试验批准通知书
智通财经 · 12-06
爱美客(300896.SZ):重组人透明质酸酶注射液获药物临床试验批准通知书
爱美客最新公告:全资子公司获得重组人透明质酸酶注射液《药物临床试验批准通知书》
证券之星 · 12-06
爱美客最新公告:全资子公司获得重组人透明质酸酶注射液《药物临床试验批准通知书》
爱美客(300896)11月29日股东户数6.09万户,较上期减少1.61%
证券之星 · 12-03
爱美客(300896)11月29日股东户数6.09万户,较上期减少1.61%
爱美客:产品具体上市时间需等待国家药监局审评结果
证券之星 · 11-20
爱美客:产品具体上市时间需等待国家药监局审评结果
海通国际:淘天品牌驱动、抖音套盒热销 双11化妆品龙头多平台增长
智通财经 · 11-20
海通国际:淘天品牌驱动、抖音套盒热销 双11化妆品龙头多平台增长
爱美客获得发明专利授权:“一种含有脱细胞生物组织材料的医用材料”
证券之星 · 11-16
爱美客获得发明专利授权:“一种含有脱细胞生物组织材料的医用材料”
爱美客(300896)11月8日股东户数6.29万户,较上期增加1.12%
证券之星 · 11-15
爱美客(300896)11月8日股东户数6.29万户,较上期增加1.12%
爱美客(300896)11月8日主力资金净卖出2.28亿元
证券之星 · 11-11
爱美客(300896)11月8日主力资金净卖出2.28亿元
海通国际:给予爱美客增持评级,目标价位299.47元
证券之星 · 11-10
海通国际:给予爱美客增持评级,目标价位299.47元
爱美客涨7.47%,德邦证券二个月前给出“买入”评级
证券之星 · 11-07
爱美客涨7.47%,德邦证券二个月前给出“买入”评级
“医美双雄”业绩承压:爱美客增速放缓,华熙生物变革阵痛
21世纪经济报道 · 11-04
“医美双雄”业绩承压:爱美客增速放缓,华熙生物变革阵痛
爱美客(300896)10月31日股东户数6.22万户,较上期增加0.3%
证券之星 · 11-04
爱美客(300896)10月31日股东户数6.22万户,较上期增加0.3%
天风证券:给予爱美客买入评级
证券之星 · 10-30
天风证券:给予爱美客买入评级
A股医美概念股局部异动,朗姿股份直线涨停,芭薇股份、爱美客、贝泰妮等短线拉升。
美港电讯 · 10-30
A股医美概念股局部异动,朗姿股份直线涨停,芭薇股份、爱美客、贝泰妮等短线拉升。
加载更多
公司概况
公司名称:
爱美客技术发展股份有限公司
所属行业:
专用设备制造业
上市日期:
2020-09-28
主营业务:
爱美客技术发展股份有限公司成是一家从事生物医用材料及生物医药产品研发与转化的国家高新技术企业。公司目前的主要产品为:基于透明质酸钠的系列皮肤填充剂、基于聚左旋乳酸的皮肤填充剂、面部埋植线产品等。公司透明质酸钠类注射产品2018至2021年在国产厂商中市场份额排名蝉联第一。公司已拥有八款获得国家药监局批准的Ⅲ类医疗器械产品,是国内获得国家药监局认证用于非手术医疗美容Ⅲ类医疗器械数量最多的企业。
发行价格:
118.27
{"stockData":{"symbol":"300896","market":"SZ","secType":"STK","nameCN":"爱美客","latestPrice":204.31,"timestamp":1734924123000,"preClose":205.18,"halted":0,"volume":1152665,"delay":0,"floatShares":209000000,"shares":303000000,"eps":6.6944,"marketStatus":"交易中","marketStatusCode":2,"change":-0.87,"latestTime":"12-23 11:22:03","open":204,"high":206.8,"low":203,"amount":236000000,"amplitude":0.0185,"askPrice":204.32,"askSize":1,"bidPrice":204.07,"bidSize":9,"shortable":0,"etf":0,"ttmEps":6.6944,"tradingStatus":2,"nextMarketStatus":{"tag":"午间休市","tradingStatus":4,"beginTime":1734924600000},"adr":0,"adjPreClose":205.18,"symbolType":"stock","openAndCloseTimeList":[[1734917400000,1734924600000],[1734930000000,1734937200000]],"highLimit":225.7,"lowLimit":184.66,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":302592061,"pbRate":8.35,"roa":"--","roe":"23.11%","epsLYR":8.6,"committee":-0.010989,"marketValue":61823000000,"floatMarketCap":42623000000,"peRate":30.519539,"changeRate":-0.0042,"turnoverRate":0.0055,"status":1},"requestUrl":"/m/hq/s/300896","defaultTab":"news","newsList":[{"id":"2491667505","title":"爱美客:公司研发项目情况会按照相关法规要求在定期报告中进行披露","url":"https://stock-news.laohu8.com/highlight/detail?id=2491667505","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491667505?lang=zh_cn&edition=full","pubTime":"2024-12-16 20:00","pubTimestamp":1734350417,"startTime":"0","endTime":"0","summary":"证券之星消息,爱美客12月16日在投资者关系平台上答复投资者关心的问题。以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024121600028532.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300896"],"gpt_icon":0},{"id":"2491434533","title":"12月13日爱美客跌5.67%,华宝中证医疗ETF基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2491434533","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491434533?lang=zh_cn&edition=full","pubTime":"2024-12-13 16:16","pubTimestamp":1734077782,"startTime":"0","endTime":"0","summary":"证券之星消息,12月13日爱美客跌5.67%,收盘报211.0元,换手率2.9%,成交量6.04万手,成交额12.96亿元。根据2024基金Q3季报公募基金重仓股数据,重仓该股的公募基金共60家,其中持有数量最多的公募基金为华宝中证医疗ETF。华宝中证医疗ETF目前规模为278.81亿元,最新净值0.3569,较上一交易日上涨0.51%,近一年下跌10.21%。华宝中证医疗ETF的前十大重仓股如下:以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024121300027495.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300896","159828","BK0251","512170"],"gpt_icon":0},{"id":"2490516835","title":"爱美客(300896)12月10日股东户数6.01万户,较上期减少1.29%","url":"https://stock-news.laohu8.com/highlight/detail?id=2490516835","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490516835?lang=zh_cn&edition=full","pubTime":"2024-12-11 17:05","pubTimestamp":1733907945,"startTime":"0","endTime":"0","summary":"证券之星消息,近日爱美客披露,截至2024年12月10日公司股东户数为6.01万户,较11月29日减少784.0户,减幅为1.29%。在医疗美容行业个股中,爱美客股东户数高于行业平均水平,截至12月10日,医疗美容行业平均股东户数为3.62万户。从股价来看,2024年11月29日至2024年12月10日,爱美客区间涨幅为2.17%,在此期间股东户数减少784.0户,减幅为1.29%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024121100028068.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300896"],"gpt_icon":0},{"id":"2490833248","title":"爱美客:截至2024年12月10日,公司股东人数为60,082户","url":"https://stock-news.laohu8.com/highlight/detail?id=2490833248","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490833248?lang=zh_cn&edition=full","pubTime":"2024-12-11 17:00","pubTimestamp":1733907631,"startTime":"0","endTime":"0","summary":"证券之星消息,爱美客(300896)12月11日在投资者关系平台上答复投资者关心的问题。投资者:请问,截至2024年十二月 10日公司的股东数是多少?谢谢爱美客董秘:尊敬的投资者您好,截至2024年12月10日,公司股东人数为60,082户。感谢您对公司的关注。以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024121100027802.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300896","BK0251"],"gpt_icon":0},{"id":"2490750280","title":"4.63亿元市值限售股今日解禁,美邦科技、外服控股、爱美客解禁市值居前","url":"https://stock-news.laohu8.com/highlight/detail?id=2490750280","media":"界面","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490750280?lang=zh_cn&edition=full","pubTime":"2024-12-11 07:38","pubTimestamp":1733873880,"startTime":"0","endTime":"0","summary":"Wind数据显示,周三,共有4家公司限售股解禁,合计解禁量为3133.89万股,按最新收盘价计算,合计解禁市值为4.63亿元。美邦科技、外服控股、普利特解禁量居前,解禁股数分别为2444.65万股、650.32万股、23.48万股。从解禁股数占总股本比例来看,1家公司解禁比例超10%。美邦科技、外服控股、爱美客解禁比例居前,解禁比例分别为29.38%、0.28%、0.05%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2024-12-11/doc-incyzuvx4259611.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2024-12-11/doc-incyzuvx4259611.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0184","BK0099","BK0020","BK0251","BK0053","BK0210","300896","BK0188","BK0234","600662"],"gpt_icon":0},{"id":"2490063839","title":"爱美客今日在互动平台表示,截至目前公司产品及服务未应用到AI技术。","url":"https://stock-news.laohu8.com/highlight/detail?id=2490063839","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490063839?lang=zh_cn&edition=full","pubTime":"2024-12-10 15:28","pubTimestamp":1733815709,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["300896","BK0251"],"gpt_icon":0},{"id":"2489288832","title":"爱美客(300896.SZ):重组人透明质酸酶注射液获药物临床试验批准通知书","url":"https://stock-news.laohu8.com/highlight/detail?id=2489288832","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489288832?lang=zh_cn&edition=full","pubTime":"2024-12-06 19:03","pubTimestamp":1733483004,"startTime":"0","endTime":"0","summary":"智通财经APP讯,爱美客(300896.SZ)公告,公司全资子公司北京诺博特生物科技有限公司近日收到国家药品监督管理局核准签发关于重组人透明质酸酶注射液的《药物临床试验批准通知书》,将于近期开展临床试验。据悉,透明质酸酶广泛应用于医疗美容、眼科手术、药物递送、辅助生殖等领域,具有分解透明质酸、辅助药物扩散、防止术后组织粘连等作用。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1221588.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1576","BK0251","BK1141","BK1583","03347","300896"],"gpt_icon":0},{"id":"2489407909","title":"爱美客最新公告:全资子公司获得重组人透明质酸酶注射液《药物临床试验批准通知书》","url":"https://stock-news.laohu8.com/highlight/detail?id=2489407909","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489407909?lang=zh_cn&edition=full","pubTime":"2024-12-06 18:30","pubTimestamp":1733481034,"startTime":"0","endTime":"0","summary":"爱美客公告,全资子公司北京诺博特生物科技有限公司收到国家药品监督管理局核准签发关于重组人透明质酸酶注射液的《药物临床试验批准通知书》,将于近期开展临床试验。该产品主要用于促进皮下输液的扩散以替代静脉输液。以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024120600034674.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["03347","BK1141","BK0251","300896","BK1583","BK1576"],"gpt_icon":0},{"id":"2488995407","title":"爱美客(300896)11月29日股东户数6.09万户,较上期减少1.61%","url":"https://stock-news.laohu8.com/highlight/detail?id=2488995407","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488995407?lang=zh_cn&edition=full","pubTime":"2024-12-03 17:08","pubTimestamp":1733216937,"startTime":"0","endTime":"0","summary":"证券之星消息,近日爱美客披露,截至2024年11月29日公司股东户数为6.09万户,较11月20日减少994.0户,减幅为1.61%。在医疗美容行业个股中,爱美客股东户数高于行业平均水平,截至11月29日,医疗美容行业平均股东户数为3.64万户。从股价来看,2024年11月20日至2024年11月29日,爱美客区间跌幅为1.89%,在此期间股东户数减少994.0户,减幅为1.61%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024120300029823.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300896","BK0251"],"gpt_icon":0},{"id":"2484161294","title":"爱美客:产品具体上市时间需等待国家药监局审评结果","url":"https://stock-news.laohu8.com/highlight/detail?id=2484161294","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484161294?lang=zh_cn&edition=full","pubTime":"2024-11-20 17:00","pubTimestamp":1732093240,"startTime":"0","endTime":"0","summary":"证券之星消息,爱美客(300896)11月20日在投资者关系平台上答复投资者关心的问题。投资者:请问贵公司的肉毒素何时才能批复投入市场?爱美客董秘:尊敬的投资者您好,产品具体上市时间需等待国家药监局审评结果。感谢您的关注。以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024112000028656.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300896"],"gpt_icon":0},{"id":"2484316362","title":"海通国际:淘天品牌驱动、抖音套盒热销 双11化妆品龙头多平台增长","url":"https://stock-news.laohu8.com/highlight/detail?id=2484316362","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484316362?lang=zh_cn&edition=full","pubTime":"2024-11-20 15:46","pubTimestamp":1732088818,"startTime":"0","endTime":"0","summary":"海通国际主要观点如下:平台:抖音抢跑实现高增长,商品卡占比提升;淘天平台GMV贡献超50%,品牌共建创造增量据蝉魔方数据统计,10月8日至11月11日抖音双11化妆品销售额同比增长69.01%,其中护肤/彩妆类目销售额分别同比增长76.81%/61.44%,护肤类目消费增长创新高。淘天平台的销售增长得益于其“回归品牌价值导向”战略。历次大促来看,天猫平台TOP4品牌保持稳定,其中2024年双11中珀莱雅从预售首日至11月11日一直位列TOP1。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1213379.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4579","MPNGY","LU1568876335.HKD","LU0541502299.USD","02367","BK1591","600729","BK1589","LU1515016050.SGD","LU0828237940.HKD","LU0348805143.USD","600859","06181","LU0449509016.USD","600694","BK4535","LU0648948544.HKD","SG9999002562.SGD","BK0170","09896","600415","HBBD.SI","300866","LU0011963245.USD","BK1583","03690","300896","BK1517","LU0314109678.HKD","LU0588545904.SGD","LU0593848301.USD","601933","603605","LU0642271901.SGD","LU1688375341.USD","LU0608807946.USD","BABA","301381","IE00B0JY6N72.USD","LU0577902371.SGD","09988","LU2293587155.HKD","BK1610","LU0831103253.SGD","89988","600612","001328","LU0067412154.USD","LU1642822792.SGD","300592"],"gpt_icon":0},{"id":"2483584896","title":"爱美客获得发明专利授权:“一种含有脱细胞生物组织材料的医用材料”","url":"https://stock-news.laohu8.com/highlight/detail?id=2483584896","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483584896?lang=zh_cn&edition=full","pubTime":"2024-11-16 03:31","pubTimestamp":1731699078,"startTime":"0","endTime":"0","summary":"证券之星消息,根据天眼查APP数据显示爱美客新获得一项发明专利授权,专利名为“一种含有脱细胞生物组织材料的医用材料”,专利申请号为CN202310074159.7,授权日为2024年11月1日。本发明的方法简单易操作,制备的含有脱细胞生物组织材料的医用材料,降解周期可调,机械强度好,生物相容性优良。今年以来爱美客新获得专利授权19个,较去年同期减少了9.52%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024111600006583.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300896"],"gpt_icon":0},{"id":"2483334190","title":"爱美客(300896)11月8日股东户数6.29万户,较上期增加1.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483334190","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483334190?lang=zh_cn&edition=full","pubTime":"2024-11-15 17:04","pubTimestamp":1731661460,"startTime":"0","endTime":"0","summary":"证券之星消息,近日爱美客披露,截至2024年11月8日公司股东户数为6.29万户,较10月31日增加696.0户,增幅为1.12%。在医疗美容行业个股中,爱美客股东户数高于行业平均水平,截至11月8日,医疗美容行业平均股东户数为3.65万户。从股价来看,2024年10月31日至2024年11月8日,爱美客区间涨幅为11.39%,在此期间股东户数增加696.0户,增幅为1.12%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024111500026994.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300896"],"gpt_icon":0},{"id":"2482217815","title":"爱美客(300896)11月8日主力资金净卖出2.28亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2482217815","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482217815?lang=zh_cn&edition=full","pubTime":"2024-11-11 09:21","pubTimestamp":1731288071,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2024年11月8日收盘,爱美客报收于237.0元,下跌3.07%,换手率3.92%,成交量8.17万手,成交额19.5亿元。近5日资金流向一览见下表:爱美客融资融券信息显示,融资方面,当日融资买入2.95亿元,融资偿还2.75亿元,融资净买入2025.15万元,连续3日净买入累计2.66亿元。爱美客主营业务:生物医用材料及生物医药的研发、生产和销售。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024111100002041.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300896"],"gpt_icon":0},{"id":"2482923228","title":"海通国际:给予爱美客增持评级,目标价位299.47元","url":"https://stock-news.laohu8.com/highlight/detail?id=2482923228","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482923228?lang=zh_cn&edition=full","pubTime":"2024-11-10 15:30","pubTimestamp":1731223830,"startTime":"0","endTime":"0","summary":"海通国际证券集团有限公司孟科含,孙旭东近期对爱美客进行研究并发布了研究报告《24Q3盈利质量提升,关注消费复苏对业绩的催化》,本报告对爱美客给出增持评级,认为其目标价位为299.47元,当前股价为237.0元,预期上涨幅度为26.36%。2024年10月宝尼达2.0正式获批,用于纠正颏部后缩,并预计于25Q1上市。根据可比公司,我们认为爱美客作为行业龙头,品牌和渠道壁垒优势突出,给予2025年38XPE,下调目标价12%至每股HKD299.47。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024111000000855.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300896"],"gpt_icon":0},{"id":"2481892914","title":"爱美客涨7.47%,德邦证券二个月前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2481892914","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481892914?lang=zh_cn&edition=full","pubTime":"2024-11-07 16:22","pubTimestamp":1730967744,"startTime":"0","endTime":"0","summary":"今日爱美客涨7.47%,收盘报244.5元。2024年8月22日,德邦证券研究员易丁依发布了对爱美客的研报《爱美客:中报业绩符合预期,25-26年储备多管线》,该研报对爱美客给出“买入”评级。此外,天风证券研究员何富丽,杨松,东吴证券研究员朱国广,吴劲草,冉胜男,张家璇,郗越近期也对该股发布了研报,同样给出“买入”评级。爱美客个股概况:以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024110700026539.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300896","161027"],"gpt_icon":0},{"id":"2480096313","title":"“医美双雄”业绩承压:爱美客增速放缓,华熙生物变革阵痛","url":"https://stock-news.laohu8.com/highlight/detail?id=2480096313","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480096313?lang=zh_cn&edition=full","pubTime":"2024-11-04 19:44","pubTimestamp":1730720696,"startTime":"0","endTime":"0","summary":"但二者近期发布的三季报,却不及市场预期:爱美客营收增速创上市以来新低,华熙生物营收净利润双降。比如,2020年9月28日上市的爱美客,正面临增速放缓的难题。今年各季度,爱美客营收和利润增速呈现出一定的波动。毛利率方面,今年前三季度,爱美客的毛利率为94.8%,同比下降0.5个百分点。2024年三季报显示,华熙生物业绩呈现下滑态势。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241104194905ab9e6a46&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241104194905ab9e6a46&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0229","300896","BK0239","688363","BK0251"],"gpt_icon":0},{"id":"2480371877","title":"爱美客(300896)10月31日股东户数6.22万户,较上期增加0.3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2480371877","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480371877?lang=zh_cn&edition=full","pubTime":"2024-11-04 17:06","pubTimestamp":1730711189,"startTime":"0","endTime":"0","summary":"证券之星消息,近日爱美客披露,截至2024年10月31日公司股东户数为6.22万户,较10月18日增加187.0户,增幅为0.3%。在医疗美容行业个股中,爱美客股东户数高于行业平均水平,截至10月31日,医疗美容行业平均股东户数为3.64万户。从股价来看,2024年10月18日至2024年10月31日,爱美客区间跌幅为3.44%,在此期间股东户数增加187.0户,增幅为0.3%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024110400022505.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300896"],"gpt_icon":0},{"id":"2479276910","title":"天风证券:给予爱美客买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2479276910","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479276910?lang=zh_cn&edition=full","pubTime":"2024-10-30 17:51","pubTimestamp":1730281914,"startTime":"0","endTime":"0","summary":"天风证券股份有限公司杨松,何富丽近期对爱美客进行研究并发布了研究报告《24Q1-3归母净利润同增12%,高基数稳健过渡》,本报告对爱美客给出买入评级,当前股价为222.2元。 爱美客 公司发布24年三季报。24年Q3公司实现营收7.19亿,yoy+1.1%,归母净利4.65亿,yoy+2.13%。最新盈利预测明细如下:该股最近90天内共有30家机构给出评级,买入评级24家,增持评级6家;过去90天内机构目标均价为269.1。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024103000035483.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300896","601162"],"gpt_icon":0},{"id":"2479249148","title":"A股医美概念股局部异动,朗姿股份直线涨停,芭薇股份、爱美客、贝泰妮等短线拉升。","url":"https://stock-news.laohu8.com/highlight/detail?id=2479249148","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479249148?lang=zh_cn&edition=full","pubTime":"2024-10-30 14:16","pubTimestamp":1730268981,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["BK0229","BK0251","BK0039","399300","300957","BK0070","BK0107","BK0048","002612","159982","BK0253","300896"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2020-09-28","address":"北京市昌平区科技园区白浮泉路10号北控科技大厦4层416B室","stockEarnings":[{"period":"1week","weight":-0.0276},{"period":"1month","weight":-0.05},{"period":"3month","weight":0.4839},{"period":"6month","weight":0.1591},{"period":"1year","weight":0.0299},{"period":"ytd","weight":-0.0164}],"companyName":"爱美客技术发展股份有限公司","boardCode":"AI0035","perCapita":"3472股","boardName":"专用设备制造业","registeredCapital":"30259万元","compareEarnings":[{"period":"1week","weight":-0.007},{"period":"1month","weight":0},{"period":"3month","weight":0.2307},{"period":"6month","weight":0.1234},{"period":"1year","weight":0.154},{"period":"ytd","weight":0.1321}],"survey":" 爱美客技术发展股份有限公司成是一家从事生物医用材料及生物医药产品研发与转化的国家高新技术企业。公司目前的主要产品为:基于透明质酸钠的系列皮肤填充剂、基于聚左旋乳酸的皮肤填充剂、面部埋植线产品等。公司透明质酸钠类注射产品2018至2021年在国产厂商中市场份额排名蝉联第一。公司已拥有八款获得国家药监局批准的Ⅲ类医疗器械产品,是国内获得国家药监局认证用于非手术医疗美容Ⅲ类医疗器械数量最多的企业。","serverTime":1734924126585,"listedPrice":118.27,"stockholders":"60082人(较上一季度减少1.29%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"爱美客(300896)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供爱美客(300896)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"爱美客,300896,爱美客股票,爱美客股票老虎,爱美客股票老虎国际,爱美客行情,爱美客股票行情,爱美客股价,爱美客股市,爱美客股票价格,爱美客股票交易,爱美客股票购买,爱美客股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"爱美客(300896)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供爱美客(300896)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}